The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives

The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives

Sarfaraz K Niazi College of Pharmacy, University of Illinois, Chicago, IL, USACorrespondence: Sarfaraz K Niazi, Tel +1-312-297-0000, Email niazi@niazi.comAbstract: Artificial intelligence (AI) and machine learning (ML) represent significant advancements in computing, building on technologies that hu...

Full description

Bibliographic Details
Main Author: Niazi SK
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Drug Design, Development and Therapy
Subjects:
fda
artificial intelligence
machine learning
drug discovery
drug development
advanced manufacturing.
Online Access:https://www.dovepress.com/the-coming-of-age-of-aiml-in-drug-discovery-development-clinical-testi-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/the-coming-of-age-of-aiml-in-drug-discovery-development-clinical-testi-peer-reviewed-fulltext-article-DDDT

Similar Items